Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

NiceRx vs Signos

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #76Desk pick
NiceRx

NiceRx (NiceRx LLC) offers compounded semaglutide ($199/mo) and compounded tirzepatide ($299/mo) with first-month promos.

Marked down on: Not available in Alaska, Mississippi, New Jersey, Kansas

vs
Dispatch #289
Signos

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with…

Marked down on: Compounded GLP-1s are not FDA-approved finished products

NiceRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

NiceRx

78/100

C+

Overall

Signos

62/100

C

Price transparency

78
68

State access

78
24

Molecule range

66
66

Onboarding speed

78
72

Support responsiveness

80
82

Licensing & trust

93
78

The spec sheet

FieldNiceRxSignos
Semaglutide$199/mo (compounded)$199/mo (6-month plan, compounded)
Tirzepatide$299/mo (compounded)$199/mo (starting dose, compounded)
Coverage46 statesCoverage not published
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forPatients seeking batch-tested compounded GLP-1 with transparent entity disclosure.Readers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.
Desk Score78/100C+62/100C

The verdict

Desk pick — NiceRx

NiceRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.

Choose NiceRx if…

Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.

$199/mo (compounded) sema · $299/mo (compounded) tirz · 46 states

Choose Signos if…

Readers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

$199/mo (6-month plan, compounded) sema · $199/mo (starting dose, compounded) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: NiceRx · Signos.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.